F Blanco-Vaca

Summary

Affiliation: Hospital de la Santa Creu i Sant Pau
Country: Spain

Publications

  1. ncbi Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein
    F Blanco-Vaca
    Servei de Bioquímica de l Hospital de la Santa Creu i Sant Pau, Antoni M Claret 167, 08025 Barcelona, Spain
    J Lipid Res 42:1727-39. 2001
  2. ncbi Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
    J C Escolà-Gil
    Servei de Bioquímica de l Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    J Lipid Res 41:1328-38. 2000
  3. ncbi ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
    J C Escolà-Gil
    Servei de Bioquimica, de l Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    J Lipid Res 42:241-8. 2001
  4. ncbi Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice
    L Calpe-Berdiel
    Institut de Recerca, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    Metabolism 57:1497-501. 2008
  5. ncbi Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension
    J Rubies-Prat
    Department of Medicine, , Spain
    Clin Exp Hypertens 23:489-500. 2001
  6. ncbi Overexpression of human apolipoprotein A-II in transgenic mice does not increase their susceptibility to insulin resistance and obesity
    J C Escolà-Gil
    Diabetologia 45:600-1. 2002
  7. ncbi Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links
    C Y Yang
    Baylor College of Medicine, Houston, Texas 77030
    Biochemistry 33:12451-5. 1994
  8. ncbi Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism
    A Perez
    Serveis d Endocrinologia, Bioquímica i Institut de Recerca, Hospital Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain
    Metabolism 53:1512-5. 2004

Collaborators

  • Antonio M Gotto
  • S Martin
  • HENRY POWNALL
  • J C Escolà-Gil
  • L Calpe-Berdiel
  • J Ordonez-Llanos
  • J Julve
  • A Perez
  • J Rubies-Prat
  • F Gonzalez-Sastre
  • A Marzal-Casacuberta
  • Noemi Rotllan
  • N Sucunza
  • E Ortega
  • R Arcelus
  • J Rodriguez-Espinosa
  • J M Cubero
  • J Pedro-Botet
  • A Goday
  • L Molina
  • C Y Yang
  • Z W Gu
  • M Yang
  • S J Gaskell
  • J B Massey

Detail Information

Publications8

  1. ncbi Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein
    F Blanco-Vaca
    Servei de Bioquímica de l Hospital de la Santa Creu i Sant Pau, Antoni M Claret 167, 08025 Barcelona, Spain
    J Lipid Res 42:1727-39. 2001
    ..We suggest that the existence of apoA-II or apoA-I in HDL could be an important signal for specific interaction with HDL receptors such as cubilin or heat shock protein 60...
  2. ncbi Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
    J C Escolà-Gil
    Servei de Bioquímica de l Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    J Lipid Res 41:1328-38. 2000
    ..We conclude that apoE-deficient mice overexpressing human apoA-II constitute useful animal models with which to study the mechanisms leading to overproduction of VLDL, and that apoA-II may function to regulate VLDL production...
  3. ncbi ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
    J C Escolà-Gil
    Servei de Bioquimica, de l Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    J Lipid Res 42:241-8. 2001
    ..These results show CETP x apoA-II-Tg mice to be a good model with which to study mechanisms leading to VLDL overproduction and suggest that CETP and, in particular apoA-II, may play a role in the regulation of VLDL metabolism...
  4. ncbi Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice
    L Calpe-Berdiel
    Institut de Recerca, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
    Metabolism 57:1497-501. 2008
    ..Phytosterol intake did not improve these metabolic parameters. Therefore, we were unable to substantiate any protective effect of phytosterol intake on diabetes development or regression in the mouse model used...
  5. ncbi Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension
    J Rubies-Prat
    Department of Medicine, , Spain
    Clin Exp Hypertens 23:489-500. 2001
    ....
  6. ncbi Overexpression of human apolipoprotein A-II in transgenic mice does not increase their susceptibility to insulin resistance and obesity
    J C Escolà-Gil
    Diabetologia 45:600-1. 2002
  7. ncbi Structure of human apolipoprotein D: locations of the intermolecular and intramolecular disulfide links
    C Y Yang
    Baylor College of Medicine, Houston, Texas 77030
    Biochemistry 33:12451-5. 1994
    ..We conclude that apoD binds to lipoprotein surfaces through structures other than alpha-helices, such as disulfide links...
  8. ncbi Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism
    A Perez
    Serveis d Endocrinologia, Bioquímica i Institut de Recerca, Hospital Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, 08025 Barcelona, Spain
    Metabolism 53:1512-5. 2004
    ..Monitoring of emerging risk factors did not offer additional arguments for treating patients with SH and, thus, is not justified in their clinical management...